215 related articles for article (PubMed ID: 3178314)
1. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).
Delecoeuillerie G; Joly P; Cohen de Lara A; Paolaggi JB
Ann Rheum Dis; 1988 Sep; 47(9):733-9. PubMed ID: 3178314
[TBL] [Abstract][Full Text] [Related]
2. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients.
Myklebust G; Gran JT
Scand J Rheumatol; 2001; 30(5):260-7. PubMed ID: 11727839
[TBL] [Abstract][Full Text] [Related]
3. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis.
Lundberg I; Hedfors E
J Rheumatol; 1990 Oct; 17(10):1340-5. PubMed ID: 2254893
[TBL] [Abstract][Full Text] [Related]
4. [Polymyalgia rheumatica and temporal arteritis. Observations on prognosis and treatment].
Auquier L; Paolaggi JB
Bull Acad Natl Med; 1990 Feb; 174(2):263-70; discussion 270-3. PubMed ID: 2372721
[TBL] [Abstract][Full Text] [Related]
5. Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients.
Mertens JC; Willemsen G; Van Saase JL; Bolk JH; Dijkmans BA
Clin Rheumatol; 1995 Nov; 14(6):650-5. PubMed ID: 8608683
[TBL] [Abstract][Full Text] [Related]
6. Polymyalgia rheumatica and corticosteroids: how much for how long?
Behn AR; Perera T; Myles AB
Ann Rheum Dis; 1983 Aug; 42(4):374-8. PubMed ID: 6882032
[TBL] [Abstract][Full Text] [Related]
7. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis.
Narváez J; Nolla-Solé JM; Clavaguera MT; Valverde-García J; Roig-Escofet D
J Rheumatol; 1999 Sep; 26(9):1945-52. PubMed ID: 10493675
[TBL] [Abstract][Full Text] [Related]
8. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
Kyle V; Hazleman BL
Ann Rheum Dis; 1993 Dec; 52(12):847-50. PubMed ID: 8311533
[TBL] [Abstract][Full Text] [Related]
9. Polymyalgia rheumatica and giant cell arteritis: a seven-year survey.
Myles AB
Rheumatol Rehabil; 1975 Nov; 14(4):231-5. PubMed ID: 1198014
[TBL] [Abstract][Full Text] [Related]
10. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
[TBL] [Abstract][Full Text] [Related]
11. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P
Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697
[TBL] [Abstract][Full Text] [Related]
13. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):662-6. PubMed ID: 2782976
[TBL] [Abstract][Full Text] [Related]
14. Anticardiolipin antibodies in the polymyalgia rheumatica-temporal arteritis syndromes.
McLean RM; Greco TP
Clin Rheumatol; 1995 Mar; 14(2):191-6. PubMed ID: 7789061
[TBL] [Abstract][Full Text] [Related]
15. Giant cell arteritis and polymyalgia rheumatica. Review for the otolaryngologist.
Ferguson BJ; Allen NB; Farmer JC
Ann Otol Rhinol Laryngol; 1987; 96(4):373-9. PubMed ID: 3619280
[TBL] [Abstract][Full Text] [Related]
16. Temporal arteritis and polymyalgia rheumatica in north-eastern Spain: clinical spectrum and relationship over a 15 year period.
Narváez J; Nolla-Solé JM; Clavaguera MT; Valverde-García J; Roig-Escofet D
Joint Bone Spine; 2003 Feb; 70(1):33-9. PubMed ID: 12639615
[TBL] [Abstract][Full Text] [Related]
17. No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids.
Haugeberg G; Myklebust G; Dovland H; Mikkelsen B; Gran JT
Scand J Rheumatol; 2000; 29(3):163-9. PubMed ID: 10898068
[TBL] [Abstract][Full Text] [Related]
18. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
19. [Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review].
Manganelli P; Mercadanti M; Nervetti A; Ambanelli U
Minerva Med; 1987 Mar; 78(5):287-96. PubMed ID: 3822219
[TBL] [Abstract][Full Text] [Related]
20. [Follow-up studies in polymyalgia rheumatica and temporal arteritis].
Li J; Tang FL; Wang XD; Yu JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):643-5. PubMed ID: 12905697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
